• Sector: Health tech
  • Technology: Nanotech
  • Investment Date: September 2020
  • Round: C, 15Ml € 
  • Co-investors: CDP Venture Capital SGR, Indaco Venture Partners SGR, Principia SGR, b-to-v Partners S.à.r.l., High-Tech-Gründerfonds II GmbH & Co., F3F S.p.A., Antares S.r.l., Agite! S.p.A., New Frontier S.r.l.
  • Founder & CEO: Luca Ravagnan

WISE Srl

WISE Srl is a Milan and Berlin-based medical device company developing a genuinely new generation of implantable leads for Neuromodulation and Neuromonitoring.
 
Currently, WISE is clinically validating its WCS electrode for intraoperative neurophysiological monitoring and completing the development of the SCS Expert lead, the first multi-column SCS paddle lead that can be implanted percutaneously by a Pain Therapist.
 
WISE’s electrodes are highly ergonomic, conformable, soft and thin, thus allowing great adhesion, minimal invasiveness and excellent adaptability on neural tissues and allowing to overcome the major limitations of today’s technology. They will allow to improve the treatment of patients that are already profiting from Neuromodulation, while at the same time expanding the use of Neuromodulation to fields and clinical indications in which the complex technical demands cannot be met by the current technology.
 
WISE’s disruptively innovative technology allows to produce electrodes that are strongly attached to the polymer and are stretchable, flexible, biocompatible [medical grade] and allow a very effective stimulation. Furthermore, SCBI allows to embed electronic circuits in foils as thin as a few microns without damaging the foil itself.
 Thanks to its technology, WISE will revolutionize the way stretchable electronics is produced, with a wide range of applications in numerous fields, such as Med-tech, Stretchable electronics, Wearable electronics, Optics, Aerospace, and beyond.

EUREKA! VIEW

WISE’s sound and consistent IP package and the material-based approach originally developed at the University of Milan nicely fits with Eureka!’s goals. The experienced management team and a clear path to the market confirms the high potential of their technology. The excellence in developing the technological platform from research to a product that is ready-to-be-launched, demonstrates that Italian technology transfer deals are feasible.”